X0708 D LIVE 0001866841 Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 780-264-4295 CANADA (FEDERAL LEVEL) None None Corporation true Cindy Jacobs c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Mark Huson c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Michael Weickert c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Executive Officer Luc G. Berthiaume c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A1 BRITISH COLUMBIA, CANADA T2P 4H2 Director John Mackey c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Ryan Heit c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Executive Officer Ajit Gill c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Nola Masterson c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Pharmaceuticals Decline to Disclose 06c false 2024-03-21 false true true false 0 75000 75000 0 This filing covers, in part, the sale of common shares issued as a result of the conversion of convertible notes. false 3 0 0 0 Pacylex Pharmaceuticals Inc. /s/ Ryan Heit Ryan Heit Chief Operating Officer 2024-04-04